Skip to main content
SpringerLink
Log in

Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL)

  • Research Articles
  • Drug Efficacy and Safety
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) therapy is frequently encountered, requiring combined treatments with sensitizing agents. It is, therefore, important to find nontoxic drugs which can be used together with TRAIL. In this study, we investigated natural compounds that can overcome resistance to TRAIL, and found that butein, a polyphenol, exhibits significant synergism with TRAIL. Treatment with TRAIL in combination with subtoxic concentrations of butein sensitizes TRAIL-resistant human leukemia U937 cells to apoptosis. Butein increased caspase-3 activity and expression of death receptor DR5. The apoptotic cell death induced by combined treatment was significantly reduced by z-DEVD-fmk, a caspase-3 inhibitor, suggesting a critical role of caspase-3 in apoptosis. These results indicate that butein sensitizes TRAIL-resistant U937 cells to TRAIL-induced apoptosis in a caspase-3 dependent manner which might be correlated with upregulation of death receptor DR5. Our data suggests that combined treatment with butein and TRAIL may provide a safe and effective strategy for treating cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

TRAIL:

tumor necrosis factor-related apoptosis-inducing ligand

TNF:

tumor necrosis factor

PBMC:

peripheral blood mononuclear cells

References

  • Bellosillo, B., Pique, M., Barragan, M., Castano, E., Villamor, N., Colomer, D., Montserrat, E., Pons, G., and Gil, J., Aspirin and salicylate induce apoptosis and activation of caspase in B-cell chronic lymphocytic leukaemia cells. Blood, 92, 1406–1414 (1998).

    PubMed  CAS  Google Scholar 

  • Bergamaschi, G., Rosti, V., Danova, M., Ponchio, L., Lucotti, C., and Cazzola, M., Inhibitors of tyrosine phosphorylation induce apoptosis in human leukaemic cell lines. Leukemia., 7, 2012–2018 (1993).

    PubMed  CAS  Google Scholar 

  • Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Tompson, G. B., bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell., 74, 597–608 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Chan, S. C., Chang, Y. S., Wang, J. P., Chen, S. C., and Kuo, S. C., Three new flavonoids and antiallergic, anti-inflammatory constituents from heartwood of Dalbergia odorifera. Planta Med., 64, 153–158 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Cheng, Z. Y., Kuo, S. C., Chan, S. C., Ko, F. N., and Teng, C. M., Antioxidant properties of butein isolated from Dalbergia odorifera. Biochim. Biophys. Acta., 1392, 291–299 (1998).

    PubMed  CAS  Google Scholar 

  • Chinnaiyan, A. M., Prasad, U., Shankar, S., Hamstra, D. A., Shanaiah, M., Chenevert, T. L., and Ross, B. D., Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizingradiation in breast cancer therapy. Proc. Natl. Acad. Sci., 97, 1754–1759 (2000).

    Article  PubMed  CAS  Google Scholar 

  • Choi, B. M., Park, R. K., Pae, H. O., Yoo, J. C., Kim, Y. C., Jun, C. D., Jung, B. H., Oh, G. S., So, H. S., Kim, Y. M., and Chung, H. T., Cyclic adenosine monophosphate inhibits ursolic acid-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells. Pharmacol. & Toxicol., 86, 53–58 (2000).

    Article  CAS  Google Scholar 

  • Constantinou, A. I., Kamath, N., and Murley, J. S., Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer., 34, 1927–1934 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Csokay, B., Prajda, N., Weber, G., and Olah, E., Molecular mechanisms in the antiproliferative action of quercetin. Life Sci., 60, 2157–2163 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Deeb, D., Xu, Y. X., Jiang, H., Gao, X., Janakiraman, N., Chapman, R. A., and Gautam, S. C., Curcumin (diferuloylmethane) enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in LNCaP prostate cancer cells. Mol. Cancer Ther., 2, 95–103 (2003).

    PubMed  CAS  Google Scholar 

  • Delmas D, Rébé C., Micheau, O., Athias, A., Gambert, P., Grazide, S., Laurent, G., Latruffe, N., and Solary, E., Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene, 24, 8979–8986 (2004).

    Article  CAS  Google Scholar 

  • Fioravanti, L., Cappelletti, V., Miodini, P., Ronchi, E., Brivio, M., and Di Fronzo, G., Geninstein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett. 130, 143–152 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Fulda, S. and Debatin, K. M., Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res., 64, 337–346 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Gibson, L., Holmgreen, S. P., Huang, D. C. S., Bernard, O., Copeland, N. G., Jenkinson, N. A., Surherland, G. R., Baker, E., Adams, J. M., and Cory, S., bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene., 13, 665–675 (1996).

    PubMed  CAS  Google Scholar 

  • Gong, L., Li, Y., Nedeljkovic-Kurepa, A., and Sarkar, F. H., Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene, 22, 4702–4709 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Gorman, A. M., Orrenius, S., and Ceccatelli, S., Apoptosis in neuronal cells: role of caspases. NeuroReport., 9, R49–R55 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Henson, E.S., Johnston, J. B., and Gibson, S. B., The role of TRAIL death receptors in the treatment of hematological malignancies. Leuk. Lymphoma, 49(1), 27–35 (2008).

    Article  PubMed  CAS  Google Scholar 

  • Jin, H., Yang, R., Fong, S., Totpal, K., Lawrence, D., Zheng, Z., Ross, J., Koeppen, H., Schwall, R., and Ashkenazi, A., Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Cancer Res., 64, 4900–4905 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Jin, X., Wu, X. X., Abdel-Muneem Nouh, M. A., and Kakehi, Y., Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic oncentrations of doxorubicin. J. Urol., 177, 1894–1899 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Kang, T. B. and Liang, N. C., Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem. Pharmacol., 54, 1013–1018 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Kim, N. Y., Pae, H. O., Kang, T. H., Kim, Y. C., Lee, H. S., and Chung, H. T., Cyclic adenosine monophosphate inhibits quinolone alkaloid evocarpine-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells. Pharmacol & Toxicol., 87, 1–5 (2000).

    Article  CAS  Google Scholar 

  • Krishan, A., Rapid flow cytometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell. Biol., 66, 188–193 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Kuo, P. L. and Lin, C. C., Green tea constituent (−)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J. Biomed. Sci., 10, 219–227 (2003)

    PubMed  CAS  Google Scholar 

  • Lepley, D. M. and Pelling, J. C., Induction of p21/WAF1 and G1 cell cycle arrest by the chemopreventive agent apigenin. Mol. Carcinogen., 19, 74–82 (1997).

    Article  CAS  Google Scholar 

  • Michels, G., Wätjen, W., Niering, P., Steffan, B., Thi, Q. H., Chovolou, Y., Kampkötter, A., Bast, A., Proksch, P., and Kahl, R., Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cells. Toxicology, 206, 337–348 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Naka, T., Sugamura, K., Hylander, B. L., Widmer, M. B., Rustum, Y. M., and Repasky, E. A., Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients’ colon tumors grown in SCID mice. Cancer Res., 62, 5800–5806 (2002).

    PubMed  CAS  Google Scholar 

  • Oltvai, Z. N., Milliman, C. L., and Korsmryer, S. J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell., 74, 609–619 (1993).

    Article  PubMed  CAS  Google Scholar 

  • Pagliacci, M. C., Smacchia, M., Migliorati, G., Grignani, F., Riccardi, C., and Nicoletti, I., Growth-inhibitory effects of the natural phyto-genistein in MCF-7 human breast cancer cells. Eur. J. Cancer., 11, 1675–1682 (1994).

    Article  Google Scholar 

  • Peták, I. and Houghton, J. A., Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol. Oncol. Res., 7, 95–106 (2001).

    Article  PubMed  Google Scholar 

  • Ramanathan, R., C. Tan, H., and Das, N. P., Cytotoxic effects of plant polyphenols and fat-soluble vitamins on malignant human cultured cells. Cancer Lett., 62, 217–214 (1992).

    Article  PubMed  CAS  Google Scholar 

  • Reed, J. C., Miyashita, T., Cuddy, M., and Cho, D., Regulation of p26-Bcl-2 protein levels in human peripheral blood lymphocytes. Am. J. Pathol., 67, 443–449 (1992).

    CAS  Google Scholar 

  • Samaha, H. S., Kelloff, G. H., Steele, V., Rao, C. V., and Reddy, B. S., Modulation of apoptosis by sulindac, curcumin, phenyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res., 57, 1301–1305 (1997).

    PubMed  CAS  Google Scholar 

  • Selvendiran, K., Koga, H., Ueno, T., Yoshida, T., Maeyama, M., Torimura, T., Yano, H., Kojiro, M., and Sata, M., Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res., 66, 4826–4834 (2006).

    Article  PubMed  CAS  Google Scholar 

  • Shankar, S., Siddiqui, I., and Srivastava, R. K., Molecular mechanisms of reseratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol. Cell. Biochem., 304, 273–285 (2007).

    Article  PubMed  CAS  Google Scholar 

  • Shao, Z. M., Wu, J., Shen, Z. Z., and Barsky, S. H., Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines. Anticancer Res., 18, 1435–1439 (1998).

    PubMed  CAS  Google Scholar 

  • Van Geelen, C. M., de Vries, E. G., and de Jong, S., Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resist. Updat., 7, 345–348 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Yang, E. B., Zhang, K., Cheng, L. Y., and Mack, P., Butein, a specific protein tyrosine kinase inhibitor. Biochem. Biophys. Res. Commun., 245, 435–438 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., and Korsmeyer, S. J., Bad, a heterodimeric parter for Bcl-xL, and Bcl-2, displaces Bax, and promotes cell death. Cell., 80, 285–291 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Yit, C. C. and Das, N. P., Cytotoxic effects of butein on human colon adenocarcinoma cell proliferation. Cancer Lett., 82, 65–72 (1994).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, and Harvard Medical School, Department of Pediatrics, Children’s Hospital Boston, Boston, MA, 02115, USA

    Nayoung Kim

Authors
  1. Nayoung Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nayoung Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, N. Butein sensitizes human leukemia cells to apoptosis induced by tumor necrosis factor-related apoptosis inducing ligand (TRAIL). Arch. Pharm. Res. 31, 1179–1186 (2008). https://doi.org/10.1007/s12272-001-1286-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12272-001-1286-2

Key words

Search

Navigation